Amyloid blood biomarker detects Alzheimer's disease

Abstract Alzheimer's disease (AD) is currently incurable, but there is general agreement that a minimally invasive blood biomarker for screening in preclinical stages would be crucial for future therapy. Diagnostic tools for detection of AD are either invasive like cerebrospinal fluid (CSF) bio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EMBO Molecular Medicine
Main Authors: Andreas Nabers, Laura Perna, Julia Lange, Ute Mons, Jonas Schartner, Jörn Güldenhaupt, Kai‐Uwe Saum, Shorena Janelidze, Bernd Holleczek, Dan Rujescu, Oskar Hansson, Klaus Gerwert, Hermann Brenner
Formato: Artigo
Publicado em: Springer Nature 2018-04-01
Assuntos:
Alzheimer's disease diagnosis
Amyloid‐β in blood plasma
BioFINDER
ESTHER
Immuno‐infrared‐sensor
Acesso em linha:https://doi.org/10.15252/emmm.201708763
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

https://doi.org/10.15252/emmm.201708763

Registos relacionados